Comparison of IASTM and Muscle Energy Technique in Patellofemoral Pain Syndrome.
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Sep 12, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different treatment methods for people with patellofemoral pain syndrome, which is a common knee problem that causes pain in the front of the knee. The trial aims to compare the effects of Instrument Assisted Soft Tissue Mobilization (IASTM) and a technique called muscle energy on reducing tightness in a muscle band along the outside of the thigh. The hope is that one of these treatments will help relieve pain, improve movement, and enhance overall function for those affected.
To participate in this trial, individuals need to be between 18 and 35 years old and have been experiencing knee pain for at least three months. Eligible participants should feel pain in their knees during activities like climbing stairs, squatting, or sitting for long periods. They should also have specific signs of knee pain when tested by a healthcare professional. However, people with certain conditions, such as knee injuries or prior surgeries, will not be able to join the study. Participants can expect to receive one of the two treatments and will be monitored throughout the trial to see how it affects their knee pain and mobility.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • • Age between 18 and 35 years
- • Both Genders.
- • Anterior or retro patellar knee pain for at least the past 3 months.
- • Knee pain during at least 3 of the following activities: ascending/descending stairs, squatting, hopping/ running, and prolonged sitting.
- • Retro patellar pain in patellar grind test (positive clarke's sign).
- • A score of at least 3 on the visual analog scale (VAS).
- • Positive Ober's test.
- Exclusion Criteria:
- • • Any meniscal or ligament tears of knee.
- • Knee osteoarthritis.
- • Any previous surgery of lower limb.
- • Patellar fracture or fracture of lower extremity.
- • Having received knee injections of corticosteroids or hyaluronic acid.
- • Osteoporosis of knee joint.
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rawalpindi, Punjab, Pakistan
Patients applied
Trial Officials
KINZA ANWAR, MS-OMPT
Principal Investigator
Riphah International University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported